Literature DB >> 2308206

'Pertussis vaccine encephalopathy': it is time to recognize it as the myth that it is.

J D Cherry.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2308206

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  11 in total

1.  Recurrent skin peeling following Kawasaki disease.

Authors:  C Michie; V Kinsler; R Tulloh; S Davidson
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

2.  The pros and cons of immunisation -- Paper two: the importance of immunisation.

Authors:  Ian D Gust
Journal:  Health Care Anal       Date:  1995-05

3.  Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule.

Authors:  I Marsili; M Pizza; F Giovannoni; G Volpini; M Bartalini; R Olivieri; R Rappuoli; L Nencioni
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

Review 4.  Immunization. Point, counterpoint.

Authors:  D W Scheifele
Journal:  CMAJ       Date:  1997-12-15       Impact factor: 8.262

5.  Toward a new vaccine for pertussis.

Authors:  John B Robbins; Rachel Schneerson; Joanna Kubler-Kielb; Jerry M Keith; Birger Trollfors; Evgeny Vinogradov; Joseph Shiloach
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-20       Impact factor: 11.205

Review 6.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

7.  Acceptance and timeliness of standard vaccination in children with chronic neurological deficits in north-western Switzerland.

Authors:  Bettina Ute Tillmann; Hanns-Christian Tillmann; Ulrich Heininger; Jürg Lütschg; Peter Weber
Journal:  Eur J Pediatr       Date:  2005-02-25       Impact factor: 3.183

8.  TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO).

Authors:  Federico Martinón-Torres; Adolfo García-Sastre; Andrew J Pollard; Carlos Martín; Albert Osterhaus; Shamez N Ladhani; Octavio Ramilo; Jose Gómez Rial; Antonio Salas; F Xavier Bosch; María Martinón-Torres; Michael J Mina; James Cherry
Journal:  Hum Vaccin Immunother       Date:  2021-11-11       Impact factor: 3.452

Review 9.  No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines.

Authors:  Thomas C Mitchell; Carolyn R Casella
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

10.  Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G.

Authors:  A Podda; L Nencioni; M T De Magistris; A Di Tommaso; P Bossù; S Nuti; P Pileri; S Peppoloni; M Bugnoli; P Ruggiero
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.